Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$3.18M Buy
62,831
+41,244
+191% +$2.17M 0.05% 601
2017
Q3
$1.12M Sell
21,587
-130,310
-86% -$6.35M 0.02% 846
2017
Q2
$7.44M Sell
151,897
-87,396
-37% -$4.05M 0.16% 204
2017
Q1
$11.3M Sell
239,293
-27,661
-10% -$1.32M 0.25% 83
2016
Q4
$12.8M Buy
266,954
+148,534
+125% +$6.81M 0.39% 21
2016
Q3
$4.69M Buy
118,420
+99,103
+513% +$3.73M 0.17% 178
2016
Q2
$685K Sell
19,317
-44,346
-70% -$1.73M 0.04% 527
2016
Q1
$2.49M Sell
63,663
-31,542
-33% -$1.18M 0.16% 135
2015
Q4
$4.09M Buy
95,205
+38,348
+67% +$1.69M 0.32% 119
2015
Q3
$2.39M Sell
56,857
-58,451
-51% -$2.73M 0.38% 40
2015
Q2
$5.75M Buy
115,308
+29,387
+34% +$1.39M 0.23% 123
2015
Q1
$3.87M Buy
85,921
+2,431
+3% +$109K 0.15% 282
2014
Q4
$4.03M Buy
83,490
+40,486
+94% +$1.92M 0.21% 147
2014
Q3
$2.06M Buy
+43,004
New +$2.09M 0.16% 257

Other funds holding MET

AHL Partners's MET Position: Q4 2017 in Review

AHL Partners increased its MetLife (MET) stake by 191% in Q4 2017, buying an estimated $2.17M and bringing the position to 62,831 shares worth $3.18M. The position accounts for 0.05% of the portfolio, ranked #601.

AHL Partners first reported a position in MET in Q3 2014 and has held it in 14 quarters since. The position peaked at $12.8M in Q4 2016. 1,084 funds tracked by Wall St. Rank hold MET as of Q4 2017.

  • AHL Partners held 62,831 shares of MetLife worth $3.18M as of Q4 2017.
  • AHL Partners bought 41,244 MetLife shares in Q4 2017, an estimated $2.17M.
  • MetLife made up 0.05% of AHL Partners's portfolio in Q4 2017, its #601 holding.
  • AHL Partners first reported a position in MetLife in Q3 2014 and has held it in 14 quarters since.
  • AHL Partners's MetLife position peaked at $12.8M in Q4 2016.
  • 1,084 funds tracked by Wall St. Rank held MetLife as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.